Back to Trials
NCT04949087NARecruiting

Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)

Rush University Medical Center

Start Date

3/13/2023

Completion Date

1/1/2028

Summary

The purpose of this study is to compare the efficacy of intra-articular corticosteroid injections versus platelet-rich plasma injections for non-operative treatment of primary glenohumeral osteoarthritis. The efficacy of intra-articular injections, outside of hyaluronic acid, for the treatment of glenohumeral OA is not known, yet these treatments are commonly used with hopes of providing patients with symptomatic relief that can hopefully delay or prevent the need for shoulder arthroplasty. This study will help elucidate the therapeutic benefit of corticosteroid and Platelet Rich Plasma (PRP) injections in this patient population.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patient ≥18y.o. of age * Primary glenohumeral arthritis (bone on bone or near bone on bone) that has been previously diagnosed on radiographs and clinical evaluation. * Baseline pain level of VAS \>4 Exclusion Criteria: * Secondary causes of arthritis (i.e. septic arthritis, rheumatoid arthritis, rotator cuff arthropathy, post-traumatic arthritis) * Ipsilateral shoulder surgery within 1 year * Any glenohumeral joint injection within 3 months * Allergy to lidocaine * Known pregnancy * Workers compensation case regarding shoulder

Interventions

PROCEDURE

Glenohumeral Injection

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Arthritis Shoulder

Locations

Rush University Medical Center

Chicago, Illinois 60612

United States